1758-98-1 Usage
General Description
4,6-Dihydroxy-2-methoxypyrimidine is a chemical compound with a pyrimidine core structure. It contains two hydroxyl groups and one methoxy group attached to the pyrimidine ring. 4,6-DIHYDROXY-2-METHOXYPYRIMIDINE is commonly used in the synthesis of pharmaceuticals and agrochemicals due to its potential as a building block for various bioactive compounds. It has also shown potential biological activities, such as antioxidant and antitumor properties. Additionally, 4,6-dihydroxy-2-methoxypyrimidine has been studied for its potential use in the treatment of various diseases and as a potential therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 1758-98-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,5 and 8 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 1758-98:
(6*1)+(5*7)+(4*5)+(3*8)+(2*9)+(1*8)=111
111 % 10 = 1
So 1758-98-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H6N2O3/c1-10-5-6-3(8)2-4(9)7-5/h2H,1H3,(H2,6,7,8,9)
1758-98-1Relevant articles and documents
Substituent and solvent effects of tautomeric equilibria of barbituric acid derivatives and isoterically related compounds
Jovanovic,Biehl
, p. 191 - 204 (1987)
-
ANTIPROLIFERATIVE PYRIMIDYL, FUSED PYRIMIDYL AND PYRIMIDYL HYDRAZONES
-
Page/Page column 49, (2010/11/27)
The present invention is related to a novel series of pyrimidyl or fused pyrimidyl hydrazones. Compounds of Formula (I) wherein A is selected from the group consisting of Formulas (A1), (A2), (A3), (A4), (A5) are useful for the treatment and/or prevention of a proliferative disease.
Piperazinyl derivatives of purines and isosteres thereof as hypoglycemic agents
-
, (2008/06/13)
There are disclosed certain 6-piperazinopurines and heteroaromatic derivatives thereof which have oral hypoglycemic acitivity and with such ability to lower blood sugar are useful in the treatment of type II diabetes and/or obesity with associated insulin